The role of electrocardiography (ECG) in prognosticating pulmonary embolism (PE) is increasingly recognized. ECG is quickly interpretable, noninvasive, inexpensive, and available in remote areas.
the publication of the Daniel score, several other studies have investigated the use of ECG as a tool for PE prognostication. These studies expanded the use of ECG and included findings not included in the Daniel score, such as ST-segment depression, ST-segment elevation (STE), Qr in lead V 1 , right axis deviation (RAD), and P pulmonale, among others. [5] [6] [7] [8] [9] [10] A recent consensus article by the International Society of Electrocardiology, the International Society for Holter and Noninvasive Electrocardiology, and the Iberoamerican Forum of Arrhythmias in the Internet demonstrated the need for a formal and comprehensive evaluation of the evidence for the use of ECG to prognosticate PE. 11 We aimed to comprehensively evaluate the data on ECG as a tool to prognosticate PE by performing a systematic review and meta-analysis of the available evidence. In this article, we focused on clinical deterioration and death as prognostic outcomes.
| METHODS
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-Analysis of Observational Studies in Epidemiology (MOOSE) statements for reporting our systematic review and meta-analysis.
We searched MEDLINE and EMBASE through February 2017 using keywords, MeSH terms, and Emtree headings. In addition, we searched Google Scholar and the Web of Science and examined abstracts, conference proceedings, and reference lists of retrieved articles. Two authors (AQ, GD) independently screened titles and abstracts and retrieved eligible articles if they (1) reported data on the prognostication of acute PE, (2) used ECG in their prognostic model, and (3) diagnosed PE formally by CT pulmonary angiogram, ventilation-perfusion scan, or autopsy. For this article, we only included studies reporting mortality, or clinical deterioration defined as any of the following: (1) new hemodynamic collapse; (2) treatment upgrading (eg, thrombolysis, surgical thrombectomy); (3) intubation or resuscitation; or (4) systolic blood pressure consistently <100 mm Hg, refractory to volume loading and requiring vasopressors. We excluded studies not written in English.
All disagreements were resolved by consensus and consultation with a senior author (AB). We extracted data in a standardized manner using an ad hoc abstraction form containing study information and quality criteria. We systematically assessed study quality by evaluating the study population, definition of outcomes and ECG findings and their assessment, attrition bias, identification of confounders, and baseline imbalance (see Supporting Information, Table, in the online version of this article).
| Statistical analysis
We analyzed data with the R package (R Foundation for Statistical Computing, http://www.r-project.org) using the DerSimonian-Laird FIGURE 1 Flow chart of the selection process for inclusion of articles in this systematic review and meta-analysis. Abbreviations: ECG, electrocardiographic; PE, pulmonary embolism random-effects model. We evaluated between-study heterogeneity using the I 2 index. 12 We reported associations as odds ratios (ORs) and 95% confidence intervals (CIs). We excluded instances in which studies had no events for a particular ECG finding and prognostic outcome, rather than performing a continuity correction in empty cells. We conducted a sensitivity analysis to evaluate whether performing a continuity correction would have changed the association.
We used a funnel plot and the Egger test to evaluate the potential for publication bias. Whenever pooling was not possible, qualitative evaluations were made on individual studies.
| RESULTS

| Article selection
There was agreement between reviewers for study screening (κ: 0.91, 95% CI: 0.86-0.96). We identified 650 unique records. Seventy studies reported the prognostication of PE using ECG, but only 39 (9198 patients) reported mortality or clinical deterioration data and met inclusion criteria ( Figure 1 ). Most included studies were retrospective cohort in design, and some studies did not appropriately control for confounders (Table 1 and Supporting Information, Table, in the online version of this article).
| In-hospital mortality
Twenty studies (4898 patients) reported data on in-hospital mortality. [4] [5] [6] [7] 9, 10, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Several ECG features were meta-analyzed for this outcome ( Table 2 ). Figure 2 shows 4 sample forest plots for the association between in-hospital mortality and each of the following ECG findings: S1Q3T3, any RBBB, TWI in precordial leads, and TWI in precordial or inferior leads. Statistically significant predictors from the meta-analysis included S1Q3T3, S1Q3T3 variations, complete RBBB, any RBBB, TWI in precordial or inferior leads, ST-segment depression in leads V 4 through V 6 , ST-segment depression in any lead, STE-V 1 , STE-III, Qr-V 1 , RAD, and atrial fibrillation (AF) at admission. Heterogeneity was generally low. Removing instances in which no events were reported for a particular ECG sign did not have a significant impact on the association compared with performing a continuity correction (data not shown). Some studies could not be pooled, and their findings are summarized in Table 2 .
Some studies reported adjusted in-hospital mortality data. Only STE-V 1 could be pooled and was found to be significantly predictive ( Table 2 ). All other adjusted in-hospital mortality data could not be pooled. Single studies identified complete RBBB and the number of leads with TWI to be significantly predictive ( interval dispersion and also found a longer mean (SD) dispersion in the group that died (89 [46] vs 65 [23] ; P = 0.001). They also reported that a QT-interval dispersion of 71.5 ms had a sensitivity of 71%, a specificity of 73%, and an area under the curve (AUC) of 0.73 (SE: 0.54; P = 0.001).
Kostrubiec et al 7 reported the median (IQR) for the Daniel score and found it to be nonsignificantly higher in patients who died: 3.5
(0-15) vs 3 (0-18). The AUC (95% CI) for a score ≥ 3 in this study was 0.52 (0.37-0.64). Toosi et al 9 also found a nonsignificantly higher mean (SD) Daniel score in patients who died: 7.5 (SD not reported) vs 4.4 (5.6). The AUC (SE) with a score ≥ 3 for this study was 0.63 (0.078).
Ermis et al 25 
| Thirty-day mortality
Eight studies (2354 patients) reported data on 30-day mortality. 22, [27] [28] [29] [30] [31] [32] [33] Statistically significant features in the meta-analysis included sinus tachycardia and AF at admission ( Table 2 ). The I 2 value was generally low. Individual studies also reported adjusted 30-day mortality data and found sinus tachycardia and right ventricular (RV) transmural ischemic pattern to be significantly predictive ( 40 They found S1Q3, abnormal QRS morphology in a Includes S1Q3T3/S1Q3, S1S2S3, S1Q3/S1rSr3 0 /S1S2S3. FIGURE 2 Sample forest plots. These 4 graphs show sample forest plots for the association between in-hospital mortality and each of the following ECG findings: S1Q3T3, any RBBB, TWI in precordial leads, and TWI in precordial or inferior leads. Abbreviations: CI, confidence interval; ECG, electrocardiographic; inf, inferior; OR, odds ratio; prec, precordial; RBBB, right bundle branch block; TWI, T-wave inversion for TWI in V 1 through V 3 , 2 points for S wave in lead I, and 3 points for sinus tachycardia. 3 They found a TwiST score ≤ 2 to have a 76% sensitivity and 59% specificity, whereas a TwiST score ≥ 5 had 52% sensitivity and 87% specificity. 3 They also computed test characteristics for the utility of the Daniel score in predicting the adverse clinical outcome and found a score ≤ 2 to have a 57% sensitivity and 74% specificity, whereas a Daniel score ≥ 7 had 44% sensitivity and 87% specificity.
| Clinical deterioration
| Risk of publication bias
Publication bias was not detected by the funnel plot, as all studies had data points falling within the 95% CI bounds (see Supporting Information, Figure, in the online version of this article). These patients have been shown to benefit from more intensive care services, including systemic or catheter-directed fibrinolysis and pulmonary selective vasodilation. [45] [46] [47] [48] 
| DISCUSSION
| Study limitations
Despite rigorous methodology, our review had some limitations. First, the assessment of publication bias was limited, as only a handful of Abbreviations: AF, atrial fibrillation; CI, confidence interval; ECG, electrocardiographic; LAD, left axis deviation; LV, left ventricular; NR, not reported; NS, not significant; OR, odds ratio; PE, pulmonary embolism; QTc, corrected QT interval; RAD, right axis deviation; RBBB, right bundle branch block; RV, right ventricular; STE, ST-segment elevation; TWI, T-wave inversion. a Includes S1Q3/S1rSr3 0 /S1S2S3/Q3T3. b Included ≥1 of: complete or incomplete RBBB, S waves in lead I combined with Q waves in lead III with or without T inversion in lead III (S1Q3T3), or inverted T waves in precordial leads V 1 , V 2 , and V 3 .
ECG finding and outcome associations had ≥10 studies, the minimum number recommended for testing funnel-plot symmetry. 49 Second, most studies were retrospective in design, and some did not control for confounders. As such, higher-quality studies, such as prospective cohort studies with appropriate controlling for confounders, are needed to more definitively assess which ECG findings can offer prognostic information in addition to currently used risk-stratification tools. Finally, some studies did not independently adjudicate ECG features and outcomes, potentially leading to misclassification bias.
| CONCLUSION
Acute PE can rapidly lead to hemodynamic collapse and death, and riskstratifying patients is imperative to determine those requiring more intensive treatment or monitoring. This meta-analysis suggests that ECG can be a valuable tool in the prognostication of PE, especially when modern technology is not accessible. Nonetheless, most studies were retrospective, and some studies did not appropriately control for confounders. Hence, more prospective cohort studies with appropriate controlling for confounders would more definitively evaluate which ECG findings can offer prognostic information in addition to currently used risk-stratification tools. These findings can aid in developing a new ECG scoring system to assist clinicians in risk-stratifying patients with PE.
